Mutations within the 5′ nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured african green monkey kidney cells

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 1041-1049

  Schultz, Derk E ^a   Honda, Masao ^b   Whetter, Linda E ^a,c   McKnight, Kevin L ^a,b   Lemon, Stanley M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; LUCIFERASE; PLASMID DNA; RNA POLYMERASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SPECIFICITY; ENCEPHALOMYOCARDITIS VIRUS; FETUS; GENE MAPPING; HEPATITIS A VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; REPORTER GENE; RNA TRANSLATION; TRANSCRIPTION INITIATION; VIRAL GENETICS; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE; CERCOPITHECUS AETHIOPS; DNA, VIRAL; DNA-DIRECTED RNA POLYMERASES; GENE EXPRESSION REGULATION, VIRAL; HEPATOVIRUS; HUMANS; LIVER; MACACA MULATTA; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BIOSYNTHESIS; RNA CAPS; RNA, VIRAL; VIRAL PROTEINS;

EID: 0030051205     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.1041-1049.1996     Document Type: Article

References (44)

1. Andino, R., G. E. Rieckhof, and D. Baltimore. 1990. A functional ribonucleoprotein complex forms around the 5′ end of poliovirus RNA. Cell 63:369-380.
2. Borman, A., M. T. Howell, J. G. Patton, and R. J. Jackson. 1993. The involvement of a spliceosome component in internal initiation of human rhinovirus RNA transition. J. Gen. Virol. 74:1775-1788.
3. Borman, A. M., F. G. Deliat, and K. M. Kean. 1994. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J 13:3149-3157.
4. Borovjagin, A., T. Pestova, and I. Shatsky. 1994 Pyrimidine tract binding protein strongly stimulates in vitro encephalomyocarditis virus RNA translation at the level of preinitiation complex formation. FEBS Lett. 351: 299-302.
5. Brown, E. A., S. P. Day, R. W. Jansen, and S. M. Lemon. 1991. The 5′ nontranslated region of hepatitis A virus: secondary structure and elements required for translation in vitro. J. Virol. 65:5828-5838.
6. Brown, E. A., A. J. Zajac, and S. M. Lemon. 1994. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5′ nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J. Virol 68:1066-1074.
7. Chang, K. H., E. A. Brown, and S. M. Lemon. 1993. Cell type-specific proteins which interact with the 5′ nontranslated region of hepatitis A virus RNA. J Virol. 67:6716-6725.
8. Chang, K. H., W. Klymstra, and S. M. Lemon. 1995. Unpublished data.
9. Cohen, J. I., B. Rosenblum, J. R. Ticehurst, R. J. Daemer, S. M. Feinstone, and R. H. Purcell. 1987. Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc. Natl. Acad. Sci. USA 84:2497-2501
10. Day, S. P., and S. M. Lemon. 1990 A single base mutation in the 5′ non-coding region of HAV enhances replication of virus in vitro, p. 175-1758. In F. Brown, R. M. Chanock, H S. Ginsberg, and R. A. Lerner (ed.), Vaccines 90: modern approaches to new vaccines including prevention of AIDS Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
11. Day, S. P., P. Murphy, E. A. Brown, and S. M. Lemon. 1992 Mutations within the 5′ nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J. Virol. 66:6533-6540.
12. Duke, G. M., M. A. Hoffman, and A. C. Palmenberg. 1992. Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol. 66:1602-1609.
13. Elroy-Stein, O., and B. Moss. 1990. Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells Proc. Natl. Acad. Sci. USA 87:6743-6747.
14. Emerson, S. U., Y. K. Huang, C. McRill, M. Lewis, and R. H. Purcell. 1992. Mutations in both the 2B and 2C genes of hepatitis A virus are invoked in adaptation to growth m cell culture. J. Virol. 66:650-654
15. Emerson, S. U., Y. K. Huang, and R. H. Purcell. 1993. 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture Virology 194:475-480.
16. Freier, S. M., R. Kierzek, J. A. Jaeger, N. Sugimoto, M. H. Caruthers, T. Neilson, and D. H. Turner. 1986. Improved free-energy parameters for predictions of RNA duplex stability. Proc. Natl. Acad Sci. USA 83:9373-9377
17. Fuerst, T. R., and B. Moss. 1989. Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells, importance of the 5′ untranslated leader. J. Mol. Biol 206: 333-348.
18. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bactenophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83: 8122-8126
19. Funkhouser, A. W., R. H. Purcell, E. D'Hondt, and S. U. Emerson. 1994. Attenuated hepatitis A virus: genetic determinants of adaptation to growth in MRC-5 cells. J. Virol. 68:148-157
20. Glass, M. J., X.-Y. Jia, and D. F. Summers. 1993 Identification of the hepatitis A virus internal ribosome entry site, in vivo and in vitro analysis of bicistronic RNAs containing the HAV 5′ noncoding region. Virology 193: 842-852.
21. Graff, J., A. Normann, S. M. Feinstone, and B. Flehmig. 1994. Nuckotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J. Virol. 68:548-554.
22. Hellen, C. U. T., G. W. Witherell, M. Schmid, S. H. Shin, T. V. Pestova, A. Gil, and E. Wimmer. 1993. A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc. Natl. Acad. Sci USA 90:7642-7646.
23. Innis, B. L., R. Snitbhan, P. Kunasol, T. Laorakpongse, W. Poopatanakool, C. A. Kozik, S. Suntayakorn, T. Suknuntapong, A. Safary, D. B. Tans, and J. W. Boslego. 1994. Protection against hepatitis A by an inactivated vaccine. JAMA 271:1328-1334
24. Jang, S. K., H.-G. Krausslich, M. J. H. Nicklin, G. M. Duke, A. C. Palmenberg, and E. C. Wimmer. 1988 A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62:2636-2643
25. Jang, S. K., and E. Wimmer. 1990. Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev, 4:1560-1572.
26. Jansen, R. W., J. E. Newbold, and S. M. Lemon. 1988 Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology 163:299-307.
27. Karron, R. A., R. J. Daemer, J. R. Ticehurst, E. D'Hondt H. Popper, K. Mihalik, J. Phillips, S. M. Feinstone, and R. H. Purcell. 1988. Studies of prototype live hepatitis A virus vaccine in primate models J Infect. Dis 157: 338-345.
28. Kozak, M. 1989 The scanning model for translation, an update. J. Cell Biol 108:229-241.
29. Lemon, S. M. 1985 Type A viral hepatitis: new developments in an old disease. N Engl. J. Med. 313:1059-1067.
30. Meerovitch, K., J. Pelletier, and N. Sonenberg. 1989. A cellular protein that binds to the 5′-noncodmg region of poliovirus RNA: implications for internal translation initiation Genes Dev. 3:1026-1034.
31. Meerovitch, K., Y. V. Svitkin, H. S. Lee, F. Lejbkowicz, D. J. Kenan, E. K. L. Chan, V. I. Agol, J. D. Keene, and N. Sonenberg. 1993. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticelocyte lysates. J. Virol. 67:3798-3807.
32. Midthun, K., E. Ellerbeck, K. Gershman, G. Calandra, D. Krah, M. Mc-Caughtry, D. Nalin, and P. Provost. 1991. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. J Infect. Dis. 163:735-739.
33. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990
34. Pelletier, J., G. Kaplan, V. R. Racaniello, and N. Sonenberg. 1988. Translational efficiency of poliovirus mRNA: mapping inhibitory cis-acting elements within the 5′ noncoding region. J. Virol. 62:2219-2227.
35. Pelletier, J., and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (London) 334:320-325.
36. Provost, P. J., and M. R. Hilleman. 1979. Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol Med. 160:213-221.
37. Ross, B. C., R. N. Anderson, P. C. Edwards, and I. D. Gust. 1989. Nucleotide sequence of high-passage hepatitis A virus strain HM175 comparison with wild-type and cell culture-adapted strains. J. Gen. Virol. 70:2805-2810
38. Shaffer, D. R., E. A. Brown, and S. M. Lemon. 1994. Large deletion mutations involving the first pyrimidine-rich tract of the 5′ nontranslated RNA of hepatitis A virus define two adjacent domains associated with distinct replication phenotypes. J. Virol. 68:5568-5578.
39. Shaffer, D. R., and S. M. Lemon. 1995. Temperature-sensitive hepatitis A virus mutants with deletions downstream of the first pyrimidine-rich tract of the 5′ nontranslated RNA are impaired in RNA synthesis J. Virol. 69:6498-6506
40. Siegl, G., and S. M. Lemon. 1990 Recent advances in hepatitis A vaccine development. Virus Res. 17:75-92.
41. Sjogren, M. H., R. H. Purcell, K. McKee, L. Binn, P. MacArthy, J. Ticehurst, S. Feinstone, J. Caudill. A. See, C. Hoke, W. Bancroft, and E. D'Hondt. 1992 Clinical and laboratory observations following oral or intramuscular administration of a live, attenuated hepatitis A vaccine candidate Vaccine 10(Suppl. 1):S135-S137.
42. Taylor, K. L., P. C. Murphy, L. V. S. Asher, J. W. LeDuc, and S. M. Lemon. 1993. Attenuation phenotype of a cell culture-adapted variant of hepatitis A virus (HM175p16) in susceptible new world owl monkeys. J. Infect. Dis. 168: 592-601.
43. Werzberger, A., B. Mensch, B. Kuter, L. Brown, J. Lewis, R. Sitrin, W. Miller, D. Shouval, B. Wiens, G. Calandra, J. Ryan, P. Provost, and D. Nalin. 1992 A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N. Engl. J. Med 327:453-457.
44. Whetter, L. E., S. P. Day, O. Elroy-Stein, E. A. Brown, and S. M. Lemon. 1994. Low efficiency of the 5′ nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells. J. Virol. 68:5253-5263.